导航治疗耐药性:雅努斯酶抑制剂治疗性结肠炎
1Acute Medicine and Gastroenterology, University of South Wales, Cardiff CF37 1DL, United Kingdom. jonathansoldera@gmail.com.
World journal of clinical cases
|August 27, 2024
概括
类激酶抑制剂,如upadacitinib和tofacitinib,显示出对治疗其他治疗耐药的严重性结肠炎 (UC) 和急性严重UC (ASUC) 的承诺. 这些小分子疗法为难以治疗的病例提供了潜在的缓解途径.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐药性性结肠炎 (UC) 和急性严重UC (ASUC) 的管理缺乏针对治疗耐药患者的标准化方法.
- 在某些严重的UC病例中,生物和便微生物群移植可能会失败,需要替代疗法.
研究的目的:
- 研究Janus激酶 (JAK) 抑制剂在严重和耐火性UC和ASUC中的疗效和安全性.
- 要突出新出现的证据,以upadacitinib和tofacitinib在治疗耐药性炎症性肠病.
主要方法:
- 对UC和ASUC中JAK抑制剂使用的临床证据和病例报告的审查.
- 在耐火病例中分析上达西提尼布和托法西提尼布治疗结果.
主要成果:
- 在对生物药物和便微生物群移植初级不响应的情况下,upadacitinib 显示出显著的疗效.
- 托法西替尼在耐火性UC和ASUC中显示出充满希望的响应率,作为单疗法或联合疗法.
- 新出现的数据表明upadacitinib在急性严重UC中是有效的.
结论:
- 小分子JAK抑制剂代表了在耐火ASUC患者中实现缓解的潜在治疗选择.
- 需要进行进一步的研究,以优化治疗抗治疗UC和ASUC患者的治疗策略.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
130
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
130
Inflammatory Bowel Disease IV: Pharmacological Management
123
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
123
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Inflammatory Bowel Disease V: Surgical Management
133
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
133
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


